{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:23:54Z","timestamp":1791624234848,"version":"4.3.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,5]]},"DOI":"10.7759\/cureus.26579","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T17:33:56Z","timestamp":1657042436000},"source":"Crossref","is-referenced-by-count":4,"title":["Building Body With Anabolics Is Weakening the Heart: Anabolic Steroid Induced Cardiomyopathy"],"prefix":"10.7759","author":[{"given":"Pradnya Brijmohan","family":"Bhattad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Roumia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2008.12.014","article-title":"Anabolics and cardiomyopathy in a bodybuilder: case report and literature review","volume":"15","author":"Ahlgrim C","year":"2009","unstructured":"Ahlgrim C, Guglin M. Anabolics and cardiomyopathy in a bodybuilder: case report and literature review. J Card Fail. 2009, 15:496-500. 10.1016\/j.cardfail.2008.12.014","journal-title":"J Card Fail"},{"key":"ref2","article-title":"[Dilated cardiomyopathy in a user of anabolic steroids]","volume":"155","author":"Schollert PV","year":"1993","unstructured":"Schollert PV, Bendixen PM. [Dilated cardiomyopathy in a user of anabolic steroids]. Ugeskr Laeger. 1993, 155:1217-8.","journal-title":"Ugeskr Laeger"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2165\/00007256-200434080-00003","article-title":"Effects of androgenic-anabolic steroids in athletes","volume":"34","author":"Hartgens F","year":"2004","unstructured":"Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med. 2004, 34:513-54. 10.2165\/00007256-200434080-00003","journal-title":"Sports Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1692","article-title":"Effects of graded doses of testosterone on erythropoiesis in healthy young and older men","volume":"93","author":"Coviello AD","year":"2008","unstructured":"Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab. 2008, 93:914-9. 10.1210\/jc.2007-1692","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1989.03420080085036","article-title":"Contrasting effects of testosterone and stanozolol on serum lipoprotein levels","volume":"261","author":"Thompson PD","year":"1989","unstructured":"Thompson PD, Cullinane EM, Sady SP, Chenevert C, Saritelli AL, Sady MA, Herbert PN. Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. JAMA. 1989, 261:1165-8.","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-15-0506","article-title":"Supra-physiological dose of testosterone induces pathological cardiac hypertrophy","volume":"229","author":"Pirompol P","year":"2016","unstructured":"Pirompol P, Teekabut V, Weerachatyanukul W, Bupha-Intr T, Wattanapermpool J. Supra-physiological dose of testosterone induces pathological cardiac hypertrophy. J Endocrinol. 2016, 229:13-23. 10.1530\/JOE-15-0506","journal-title":"J Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/14017431.2014.976837","article-title":"Characteristics and outcome of patients with heart failure due to anabolic-androgenic steroids","volume":"48","author":"S\u00f8ndergaard EB","year":"2014","unstructured":"S\u00f8ndergaard EB, Thune JJ, Gustafsson F. Characteristics and outcome of patients with heart failure due to anabolic-androgenic steroids. Scand Cardiovasc J. 2014, 48:339-42. 10.3109\/14017431.2014.976837","journal-title":"Scand Cardiovasc J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt B","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, et al.. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016, 134:e579-646. 10.1161\/CIR.0000000000000455","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.026945","article-title":"Cardiovascular toxicity of illicit anabolic-androgenic steroid use","volume":"135","author":"Baggish AL","year":"2017","unstructured":"Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, Pope HG Jr. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. 2017, 135:1991-2002. 10.1161\/CIRCULATIONAHA.116.026945","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000177333","article-title":"Anabolic steroid use as the possible precipitant of dilated cardiomyopathy","volume":"88","author":"Ferrera PC","year":"1997","unstructured":"Ferrera PC, Putnam DL, Verdile VP. Anabolic steroid use as the possible precipitant of dilated cardiomyopathy. Cardiology. 1997, 88:218-20. 10.1159\/000177333","journal-title":"Cardiology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/100067-building-body-with-anabolics-is-weakening-the-heart-anabolic-steroid-induced-cardiomyopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:42Z","timestamp":1707507582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/100067-building-body-with-anabolics-is-weakening-the-heart-anabolic-steroid-induced-cardiomyopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,5]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.26579","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,5]]}}}